# Liothyronine sodium

NDC: 70377-114
Generic name: Liothyronine sodium
Labeler / Manufacturer: Biocon Pharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20240212

FDA application: ANDA218070

## Active ingredients

- LIOTHYRONINE SODIUM: 5 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70377-114"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70377-114
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21002702-422b-1402-73b8-670314d8e579